期刊文献+

5-硝基-2-氨基苯甲腈与环己酮的竞争反应工艺条件研究

Study on Competitive Reaction of 5-Nitro-2-aminobenzylnitrile with Cyclohexanone
原文传递
导出
摘要 5硝基2氨基苯甲腈与环己酮反应可以按不同的反应机理得到7硝基他克林和2H3,1苯并噁嗪衍生物。研究了不同条件下生成二者的竞争反应工艺条件及反应机理,发现用三氯化铝作催化剂时,产物以7硝基他克林为主;改用无水氯化锌作催化剂时,产物以2H3,1苯并噁嗪衍生物为主。前者的生成是动力学控制,后者的生成是热力学控制。 Owing to the different mechanism of the reactions between 5-nitro-2-aminobenzylnitrile with cyclohexanone, either 7-nitrotacrine or 2H-3,1-benzoxazine derivatives can be obtained. If using AlCl3 as catalyst, the product is mainly 7- nitrotacrine, if using anhydrous ZnCl2 as catalyst, the product is mainly 2H-3,1-benzoxazine. It is found that the formation of 7-nitrotacrine is controlled by dynamic factor, whereas the formation of 2H3,1-benzoxazine is controlled by thermodynamic factor.
出处 《精细与专用化学品》 CAS 2006年第12期21-24,共4页 Fine and Specialty Chemicals
关键词 他克林 2H-1 3-苯并噁嗪 5-硝基-2-氨基苯甲腈 环己酮 tacrine 2H-3,1-benzoxazine 5-nitro-2-aminobenzylnitrile cyclohexanone
  • 相关文献

参考文献9

  • 1[1]P W Zhang,A Fensome.Cyclothiocarbonate derivatives as progesterone receptor modulators[P].WO0066570,2000-11-09
  • 2[2]A A Santilli,P W Zhang,A K Viet,et al.Cyclocarbonate and cyclic amide derivarives[P].WO0066591,2000-11-09
  • 3[3]P W Zhang,E A Terefenko,A Fensome,Bioorg Med.Chem.Lett.,2003,13:1313
  • 4[4]E V Gromachevskaya,N INen' ko,Method of melting bitumen from waste bitumen roll materials[P].RU2195475,2002-12-27
  • 5[5]G S Grubb,L Zhi,T K Jones,Contraceptive compositions containing quinazolinone and benzoxazine derivatives[P].WO0066165,2000-11-09
  • 6[6]Summers W K,Majovski L V,Marsh G MN.Oral tetrahydroacridine in long-term treatment of senile dementia,Alzheimer type[J].The new Engl.J.Med,1986,315:1241 ~1245
  • 7[7]Eagger S A,Levy R,Sahakian B J.Tacrine in Alzheimer's disease[J].Lancet,1991,337:989 ~ 992
  • 8李加荣,郭永建,杨新华,李媛艳.他克林衍生物及其类似物的研究进展[J].中国药物化学杂志,2003,13(1):51-56. 被引量:6
  • 9李加荣,杨新华,李媛艳,郭永建.他克林二联体类似物的合成和药理研究进展[J].合成化学,2003,11(3):209-212. 被引量:7

二级参考文献37

  • 1胡明宽 邵佳驹.用于治疗老年痴呆症的他克林衍生物[P].CN 128 893A.2001.
  • 2李加荣 周馨我.氨基吖啶的改进制备[P].CN 12 222 512A.1999.
  • 3李加荣 周馨我.制备氨基吖啶的改进制备[P].CN:12222512A.1999-08-12.
  • 4Wang H, Carlier P R,Ho W L et al. Neuroreport[J].1999,10: 789--793.
  • 5Wang H,Carlier P R,Pang Y P. Aeta Pharmaeolosica Siniea [J]. 1999,20:211-217.
  • 6Liu J,Ho W,Lee N T, et al. Neurosci. Lett. [J]. 2000,282:165--168.
  • 7Han Y,Wu D,Xlao X,et al. Neurosci. Lett [J]. 2000,288,95--98.
  • 8Hu M K, Shaw J J T. Tacrine Derivatives for Treating Alzheimer Disease[P]. LS 6 194 403,2001.
  • 9Pang Y P,Hong F, Quiram P,et al. Journal of Chem Soc.Perkin.Trans.I[J]. 1997.171-176.
  • 10Carlier P R,Han Y F,Chow E S, et al. Bioorg.Med.Chem.[J]. 1999,7(2) : 351-357.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部